Authors:
REGAZZI MB
RUSSO D
IACONA I
SACCHI S
VISANI G
LAZZARINO N
AVVISATI G
PELICCI PG
DASTOLI G
GRANDI C
SPREAFICO S
GRATTONI R
GALIENI P
RUPOLI S
MAIOLO AM
GUERRA E
LIBERATI AM
Citation: Mb. Regazzi et al., TIME-DEPENDENT KINETICS OF TRETINOIN IN CHRONIC MYELOGENOUS LEUKEMIA DURING INTERMITTENT DOSE SCHEDULING - 1 WEEK ON 1 WEEK OFF, Clinical drug investigation, 16(1), 1998, pp. 25-33
Authors:
RUSSO D
REGAZZI M
SACCHI S
VISANI C
LAZZARINO M
AVVISATI G
PELICCI PG
DASTOLI G
GRANDI C
IACONA I
CANDONI A
GRATTONI R
GALIENI P
RUPOLI S
LIBERATI AM
MAIOLO AT
Citation: D. Russo et al., ALL-TRANS-RETINOIC ACID (ATRA) IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA IN THE CHRONIC PHASE, Leukemia, 12(4), 1998, pp. 449-454
Authors:
PALMERI S
MELI M
DANOVA M
BERNARDO G
LEONARDI V
DASTOLI G
RAUSA L
RUSSO A
FILIPELLI G
PALMIERI G
RUSSO A
SCARPATI MD
LORUSSO V
DILAURO L
COLUCCI G
BRUNI G
PIAZZI M
GEBBIA N
SPADA S
Citation: S. Palmeri et al., 5-FLUOROURACIL PLUS INTERFERON ALPHA-2A COMPARED TO 5-FLUOROURACIL ALONE IN THE TREATMENT OF ADVANCED COLON-CARCINOMA - A MULTICENTRIC RANDOMIZED STUDY, Journal of cancer research and clinical oncology, 124(3-4), 1998, pp. 191-198
Authors:
REGAZZI MB
TOMA S
BERNARDO G
IACONA I
DASTOLI G
MOLINARO V
SPREAFICO S
Citation: Mb. Regazzi et al., TIME AND DOSE-DEPENDENCY OF TRETINOIN DURING TREATMENT OF BREAST-CANCER, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4736-4736
Authors:
TOMA S
ISNARDI L
RAFFO P
RICCARDI L
DASTOLI G
APFEL C
LEMOTTE P
BOLLAG W
Citation: S. Toma et al., RAR-ALPHA ANTAGONIST RO-41-5253 INHIBITS PROLIFERATION AND INDUCES APOPTOSIS IN BREAST-CANCER CELL-LINES, International journal of cancer, 78(1), 1998, pp. 86-94
Authors:
TOMA S
RAFFO P
ISNARDI L
RICCARDI L
DEFRANCISCI E
MASELLI G
DASTOLI G
PALUMBO R
Citation: S. Toma et al., ASSOCIATIONS OF RETINOIDS, TAMOXIFEN AND ALPHA-INTERFERON 2A IN HUMANBREAST-CANCER - IN-VITRO AND IN-VIVO STUDIES, International journal of oncology, 10(3), 1997, pp. 597-607
Authors:
TOMA S
MASELLI G
DASTOLI G
DEFRANCISCI E
RAFFO P
Citation: S. Toma et al., SYNERGISTIC EFFECT BETWEEN DOXORUBICIN AND A LOW-DOSE OF ALL-TRANS-RETINOIC ACID IN MCF-7 BREAST-CANCER CELL LINE, Cancer letters, 116(1), 1997, pp. 103-110
Authors:
TOMA S
ISNARDI L
RAFFO P
DASTOLI G
DEFRANCISCI E
RICCARDI L
PALUMBO R
BOLLAG W
Citation: S. Toma et al., EFFECTS OF ALL-TRANS-RETINOIC ACID AND 13-CIS-RETINOIC ACID ON BREAST-CANCER CELL-LINES - GROWTH-INHIBITION AND APOPTOSIS INDUCTION, International journal of cancer, 70(5), 1997, pp. 619-627
Authors:
RUSSO D
IACONA I
REGAZZIBONORA M
LAZZARINO M
SACCHI S
AVVISATI G
VISANI G
PELICCI PG
DASTOLI G
GRASSI C
FOWST C
Citation: D. Russo et al., PHARMACOKINETIC PROFILE OF ALL-TRANS-RETINOIC ACID (ATRA) INTERMITTENTLY ADMINISTERED IN DIFFERENT HEMATOLOGIC DISEASES, Experimental hematology, 24(9), 1996, pp. 583-583
Authors:
OLIVERI F
SANTANTONIO T
BELLATI G
COLLOREDO G
COLOMBATTO P
DASTOLI G
BONINO F
BRUNETTO MR
Citation: F. Oliveri et al., LONG-TERM MONTHLY FOLLOW-UP OF PATIENTS CHRONIC ANTI-HBE POSITIVE HEPATITIS-B TREATED DIFFERENT INTERFERON TYPES AND SCHEDULES, Hepatology, 23(1), 1996, pp. 201-201
Authors:
SACCHI S
REGAZZI MB
AVVISATI G
DASTOLI G
GALLIENI P
GRASSI C
LAZZARINO M
LIBERATI AM
MAIOLO AT
PELICCI PG
RUPOLI S
VISANI G
RUSSO D
Citation: S. Sacchi et al., PHASE I II STUDY OF THE BIOLOGICAL-ACTIVITY OF ALL-TRANS-RETINOIC ACID IN PATIENTS WITH PH(1)(+) CHRONIC MYELOID-LEUKEMIA/, Blood, 88(10), 1996, pp. 3532-3532
Authors:
OLIVERI F
SANTANTONIO T
BELLATI G
COLLOREDO G
COLOMBATTO P
DASTOLI G
BONINO F
BRUNETTO MR
Citation: F. Oliveri et al., LONG-TERM MONTHLY FOLLOW-UP OF PATIENTS WITH CHRONIC ANTI-HBE POSITIVE HEPATITIS-B TREATED WITH DIFFERENT INTERFERON TYPES AND SCHEDULES, Hepatology, 22(4), 1995, pp. 1448-1448
Authors:
PAPINESCHI F
BUCALOSSI A
CAPOCHIANI E
BENEDETTI E
BRAMANTI E
DASTOLI G
DISPENSA E
BENEDETTI E
SPREMOLLA G
Citation: F. Papineschi et al., RECOMBINANT ALPHA-2A INTERFERON AND POLYCYTHEMIA-VERA - CLINICAL-RESULTS AND BIOLOGICAL EVALUATION BY MEANS OF FOURIER-TRANSFORM INFRARED MICROSPECTROSCOPY, European journal of haematology, 53(4), 1994, pp. 213-217
Authors:
BARBERA C
BORTOLOTTI F
CRIVELLARO C
COSCIA A
ZANCAN L
CADROBBI P
NEBBIA G
PILLAN MN
LEPORE L
PARRELLA T
DASTOLI G
BRUNETTO MR
BONINO F
Citation: C. Barbera et al., RECOMBINANT INTERFERON-ALPHA(2A) HASTENS THE RATE OF HBEAG CLEARANCE IN CHILDREN WITH CHRONIC HEPATITIS-B, Hepatology, 20(2), 1994, pp. 287-290
Authors:
BARBERA C
CALVO P
COSCIA A
PERUGINI L
DASTOLI G
RANDONE A
BONINO F
BRUNETTO MR
Citation: C. Barbera et al., PRECORE MUTANT HEPATITIS-B VIRUS AND OUTCOME OF CHRONIC INFECTION ANDHEPATITIS IN HEPATITIS-B E-ANTIGEN-POSITIVE CHILDREN, Pediatric research, 36(3), 1994, pp. 347-350
Authors:
NEGRO F
BALDI M
MONDARDINI A
LEANDRO G
CHANEAC M
MANZINI P
ABATE ML
ZAHM F
DASTOLI G
BALLARE M
RYFF JC
VERME G
BONINO F
Citation: F. Negro et al., CONTINUOUS VERSUS INTERMITTENT THERAPY FOR CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON ALFA-2A, Gastroenterology, 107(2), 1994, pp. 479-485